top of page

Process
Technology
Partnerships
News
Contact
About
More

Use tab to navigate through the menu items.

Qubigen data representation

News

Qubigen to Attend BIO 2025 in Boston: Seeking Collaborations and Partnerships

Qubigen to Attend BIO 2025 in Boston: Seeking Collaborations and Partnerships

Qubigen to Attend BIO 2025 in Boston: Seeking Collaborations and Partnerships

Qubigen is excited to announce our participation in the upcoming BIO International Convention 2025, taking place from June 16–19 at the Boston Convention & Exhibition Center. As one of the largest gatherings in the biotechnology industry, BIO 2025 offers a unique platform for networking, collaboration, and innovation.

Apr 233 min read

Qubigen Unlocks Second Tranche of Pre-Seed Investment Ahead of Schedule Following Advanced Results with Federated AI Drug Design

Qubigen Unlocks Second Tranche of Pre-Seed Investment Ahead of Schedule Following Advanced Results with Federated AI Drug Design

Qubigen Unlocks Second Tranche of Pre-Seed Investment Ahead of Schedule Following Advanced Results with Federated AI Drug Design

Qubigen is excited to announce that it has unlocked the second tranche of pre-seed investment from SYNthesis BioVentures ahead of...

Mar 162 min read

Qubigen Applies Federated AI to Generate Novel Candidates for First Drug Development Client

Qubigen Applies Federated AI to Generate Novel Candidates for First Drug Development Client

Qubigen Applies Federated AI to Generate Novel Candidates for First Drug Development Client

Qubigen reports the successful application of its Federated AI-Drug Design platform in collaboration with our first Drug Development...

Feb 283 min read

enquiries@qubigen.com

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Accelerate drug design
without exposing secrets

Connect with Us

© 2025 Qubigen. All rights reserved.

bottom of page